Is there a role for targeted medical therapies in patients with craniopharyngiomas?

    loading  Checking for direct PDF access through Ovid

Abstract

“Our understanding of the molecular mechanisms underlying papillary craniopharyngiomas has been advanced as a result of recent observations implicating somatic BRAF gene mutations in the pathogenesis of these uncommon, yet potentially devastating, tumors.”

Related Topics

    loading  Loading Related Articles